Showing results (121-130 of 232) with videos related to

Sort By:
Pageof 24
Medicina Clinica|March 6, 1993
[Endocarditis due to penicillin-sensitive and -resistant pneumococci: the current perspectives on the disease]J M Aguado, A Casillas, M Lizasoaín, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2016
Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream InfectionsM Puig-Asensio, M Fernández-Ruiz, J M Aguado, et al.
Revista Clinica Espanola|March 28, 1998
[Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients]P Cobo Reinoso, J M Aguado García, C Lumbreras Bermejo, et al.
The Journal of Hospital Infection|December 4, 2025
Implementation of a novel aseptic insertion device for peripheral venous catheters: safety, performance, and nurse satisfactionT Ruiz-Merlo, A I Sánchez Morgado, P Brañas, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 14, 2012
Safety of anidulafungin in solid organ transplant recipientsJ M Aguado, E Varo, P Usetti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 12, 2015
Risk factors for metastatic osteoarticular infections after a long follow-up of patients with Staphylococcus aureus bacteraemiaA Lalueza, A Morales-Cartagena, F Chaves, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 30, 2008
Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplantAngel Asensio, Antonio Ramos, Valentin Cuervas-Mons, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 16, 2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)K L Winthrop, X Mariette, J T Silva, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 19, 2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)M Reinwald, J T Silva, N J Mueller, et al.
Pageof 24